The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 11, 2023
Filed:
Mar. 14, 2019
Applicants:
A2a Pharmaceuticals, Inc., New York, NY (US);
Oncocube Therapeutics Llc, Wilmington, DE (US);
Inventors:
Erden Banoglu, Ankara, TR;
Burcu Caliskan, Ankara, TR;
Ozgur Sahin, Lexington, SC (US);
Deniz Lengerli, Ankara, TR;
Ozge Akbulut, Ankara, TR;
Assignees:
A2A Pharmaceuticals, Inc., New York, NY (US);
OncoCube Therapeutics LLC, Wilmington, DE (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5377 (2013.01); A61P 35/00 (2018.01);
Abstract
The present invention relates to a new inhibitor chemotype 3-(4-methoxyphenyl)-N-(2-morpholinopyrimidin-4-yl) isoxazol-5-amine (BO-264) targeting TACC3 protein with high potency as a mitotic blocker for the treatment of breast and potentially other cancers.